Study guide
12.1 Federal Confidentiality Regulations: 42 CFR Part 2 and HIPAA Integration
National Certified Addiction Counselor NCAC
Track your progress as you read
Finished sections get a check mark.
1 Introduction to NCAC & Addiction Counseling
0.1 NCAC Exam Structure, Eligibility, and Scoring 0.2 The 12 Core Functions & TAP 21 Addiction Counseling Competencies 0.3 Study Strategy and Exam Navigation for Addiction Counselors
2 Chapter 1: Screening, Intake, and Initial Orientation
1.1 Screening Instruments, Risk Stratification, and SBIRT Protocols 1.2 The Intake Process: Clinical and Administrative Data Collection 1.3 Client Orientation, Rights, Informed Consent, and Program Expectations 1.4 Mandated, Court-Referred, and Justice-Involved Clients
3 Chapter 2: Initial Case Management and Referral Foundations
2.1 Stages of Change (Transtheoretical Model) and Initial Engagement 2.2 Referral Coordination, Community Resources, and Interdisciplinary Linkage 2.3 Harm Reduction, Overdose Prevention, and Low-Threshold Engagement
4 Chapter 3: Biopsychosocial Assessment & Diagnostic Foundations
3.1 Comprehensive Biopsychosocial Assessment & The Addiction Severity Index (ASI) 3.2 DSM-5-TR Substance Use Disorders: Criteria, Specifiers, and Neurobiology of Addiction 3.3 Behavioral and Process Addictions: Assessment and Clinical Features 3.4 Models and Theories of Addiction Etiology
5 Chapter 4: Co-Occurring Disorders & Risk Assessment
4.1 Co-Occurring Mental Health Disorders & Differential Diagnosis 4.2 Suicide Risk Assessment, Self-Harm, and Crisis Safety Planning 4.3 Trauma-Informed Assessment, PTSD, and Adverse Childhood Experiences (ACEs)
6 Chapter 5: Medical, Toxicology, and Special Population Considerations
5.1 Medical Evaluation, Toxicology Screening, and Infectious Disease Risks 5.2 Cultural, Developmental, and Special Population Assessment Adaptations 5.3 Psychopharmacology of the Major Drug Classes 5.4 Physiological Effects of Substance Use Across Body Systems
7 Chapter 6: The ASAM Criteria & Level of Care Placement
6.1 The ASAM Criteria: The Six Multidimensional Assessment Dimensions 6.2 ASAM Continuum of Care: Levels 0.5 Through 4.0 6.3 Placement Matching, Continued Service, Transfer, and Discharge Criteria
8 Chapter 7: Individualized Treatment Planning & Pharmacotherapy
7.1 Developing Measurable, Individualized Treatment Plans (SMART Objectives) 7.2 Medications for Addiction Treatment (MAT/MOUD) and Pharmacotherapies 7.3 Monitoring Clinical Progress, Plan Review, and Interdisciplinary Care
9 Chapter 8: Case Management, Relapse Prevention & Continuing Care
8.1 Case Management Models, Advocacy, and Resource Coordination 8.2 Relapse Dynamics, Warning Signs, and Relapse Prevention Models 8.3 Continuing Care, Recovery Capital, and Peer Support Systems 8.4 Clinical Documentation, Progress Notes, and the Golden Thread 8.5 Outcome Measurement, Program Evaluation, and Evidence-Based Practice
10 Chapter 9: Core Counseling Modalities & Individual Skills
9.1 Motivational Interviewing: Spirit, Principles, OARS, and Change Talk 9.2 Cognitive Behavioral Therapy (CBT) & REBT in Addiction Treatment 9.3 Additional Evidence-Based Approaches: SFBT, Contingency Management, and Mindfulness 9.4 Mutual-Help Programs, Twelve-Step Facilitation, and Recovery Support
11 Chapter 10: Group Dynamics & Family Systems
10.1 Group Counseling Dynamics, Types of Groups, and Yalom's Therapeutic Factors 10.2 Group Leadership Skills, Managing Challenging Behaviors, and Developmental Stages 10.3 Family Systems Theory, Roles, Codependency, and Family Interventions
12 Chapter 11: Crisis Intervention & Psychoeducation
11.1 Crisis Intervention Models, De-escalation Techniques, and Overdose Response 11.2 Psychoeducation, Health Literacy, and Client Self-Advocacy
13 Chapter 12: Legal Standards, Confidentiality & 42 CFR Part 2
12.1 Federal Confidentiality Regulations: 42 CFR Part 2 and HIPAA Integration 12.2 Duty to Warn / Protect (Tarasoff) and Mandated Reporting Laws 12.3 Legal Issues, Subpoenas, Court Mandates, and Clinical Record Retention 12.4 Confidentiality with Minors, Groups, Families, and Collaterals
14 Chapter 13: NAADAC Ethics, Cultural Humility & Supervision
13.1 The NAADAC Code of Ethics: Core Principles, Boundaries, and Dual Relationships 13.2 Cultural Humility, Implicit Bias, and Culturally Responsive Care 13.3 Clinical Supervision, Professional Impairment, Compassion Fatigue, and Self-Care 13.4 Technology in Practice: Telehealth, E-Supervision, AI, and Social Media 13.5 Professional Development, Credentialing, and Scope of Practice
12.1 Federal Confidentiality Regulations: 42 CFR Part 2 and HIPAA Integration
Key Takeaways Explain This Topic AI
42 CFR Part 2 was promulgated under the Public Health Service Act to strictly protect the confidentiality of substance use disorder (SUD) patient records, preventing criminal prosecution, social discrimination, and treatment deterrence.
A 'Covered Program' under Part 2 is any individual or entity that is federally assisted (via federal funding, tax-exempt status, Medicare/Medicaid participation, or DEA registration) and 'holds itself out' as providing SUD diagnosis, treatment, or referral.
A valid Part 2 consent form strictly requires all nine mandatory elements, including explicit disclosing and recipient entities, exact types of data, expiration date/event, and mandatory revocation rights, accompanied by the § 2.32 notice prohibiting unauthorized redisclosure.
The CARES Act Section 3221 and the Part 2 Final Rule — published February 16, 2024, effective April 16, 2024, and enforceable since the February 16, 2026 compliance date — aligned Treatment, Payment, and Operations consent with HIPAA, established a single consent for ongoing TPO disclosures, imposed HITECH civil penalty parity, and expanded anti-discrimination protections.
Non-consensual disclosures under Part 2 are strictly restricted to bona fide medical emergencies (§ 2.51), authorized scientific research (§ 2.52), regulatory program audits (§ 2.53), Qualified Service Organization Agreements (QSOAs / § 2.11), mandated child abuse reports (§ 2.12(c)(6)), on-premises crimes (§ 2.12(c)(5)), and Subpart E authorizing court orders.
Last updated: August 2026
Federal Confidentiality Regulations: 42 CFR Part 2 and HIPAA Integration
Confidentiality is the ethical bedrock and legal cornerstone of addiction counseling. Individuals seeking treatment for Substance Use Disorders (SUD) frequently disclose highly sensitive, stigmatizing, and potentially incriminating information regarding illicit drug use, past unlawful activities, medical conditions, and familial dysfunction. Historically, the fear of public exposure, social ostracization, employment termination, loss of housing, child custody forfeiture, and criminal prosecution prevented millions of individuals from entering addiction treatment.
To dismantle these systemic barriers, the United States Congress enacted specialized federal confidentiality legislation that provides significantly heightened privacy safeguards for addiction treatment records compared to standard medical records. Addiction professionals must navigate two distinct federal privacy frameworks: the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy and Security Rules (45 CFR Parts 160 and 164) and the specialized regulations governing Confidentiality of Substance Use Disorder Patient Records codified in Title 42 of the Code of Federal Regulations, Part 2 (42 CFR Part 2) . +-----------------------------------------------------------------------------+
- | THE DUAL PILLARS OF ADDICTION PRIVACY LAW |
- | |
- | [HIPAA PRIVACY RULE (45 CFR)] [42 CFR PART 2 REGULATIONS] |
- | • Broad healthcare baseline • Specialized SUD heightened privacy |
- | • Governs Covered Entities • Governs 'Covered Programs' |
- | • Permits TPO without consent • Historically required strict consent |
- | • Modernized & Harmonized under CARES Act Section 3221 (2024/2026 Rules) |
- +-----------------------------------------------------------------------------+
- 1. Historical Origins and Legislative Intent of 42 CFR Part 2
Promulgated pursuant to Section 543 of the Public Health Service Act (originally enacted under the Drug Abuse Prevention, Treatment, and Rehabilitation Act of 1972, codified at 42 U.S.C. § 290dd-2 ), 42 CFR Part 2 was designed with an explicit public health objective: to encourage individuals with substance use disorders to seek treatment by guaranteeing that their treatment records will not be weaponized against them in criminal proceedings, civil lawsuits, or discriminatory administrative actions.
Unlike general medical records laws that balance privacy against broad clinical administrative convenience, 42 CFR Part 2 establishes an overarching presumption of absolute confidentiality . The regulations strictly prohibit the disclosure and use of patient-identifying SUD records unless specifically authorized by the patient's explicit written consent or under a narrow set of statutory exemptions.
2. Scope and Jurisdictional Applicability: Defining a "Covered Program"
42 CFR Part 2 does not apply universally to every healthcare setting. Rather, jurisdiction is established through a strict two-prong legal test : the entity must be (1) Federally Assisted AND (2) meet the definition of a Part 2 Program . +-----------------------------------------------------------------------------+
- | 42 CFR PART 2 JURISDICTIONAL APPLICABILITY |
- | |
- | PRONG 1: FEDERALLY ASSISTED PRONG 2: 'HOLDS ITSELF OUT' |
- | • Federal grant/contract funding • Specialized SUD facility |
- | • Tax-exempt 501(c)(3) status • Specialized unit within hospital |
- | • Medicare/Medicaid provider • Dedicated SUD staff / medical role |
- | • DEA registration for MOUD • Primary function: SUD dx/tx/referral |
- | |
- | [BOTH PRONGS MET = 42 CFR PART 2 COVERED PROGRAM] |
- +-----------------------------------------------------------------------------+
- Prong 1: Federal Assistance (§ 2.12(b))
An entity is deemed federally assisted if it satisfies any of the following criteria:
Direct Federal Funding: Receives federal funds in any form, including Substance Abuse Prevention and Treatment (SAPT) Block Grants, SAMHSA grants, or federal contracts.
Tax-Exempt Status: Is recognized as a tax-exempt non-profit organization under Section 501(c)(3) of the Internal Revenue Code.
Public Healthcare Participation: Is certified to participate in and receive reimbursement from Medicare (CMS) or Medicaid.
DEA Controlled Substance Registration: Employs practitioners registered with the Drug Enforcement Administration (DEA) who dispense or prescribe controlled substances (Schedule II–V) for SUD treatment, including Medications for Opioid Use Disorder (MOUD) such as methadone, buprenorphine, or naltrexone.
Federal Operation: Is operated directly by the federal government (e.g., Veterans Health Administration, Indian Health Service, Department of Defense).
Prong 2: Definition of a "Program" (§ 2.11)
A federally assisted individual or entity is a Part 2 "Program" if it "holds itself out" as providing, and provides, alcohol or drug abuse diagnosis, treatment, or referral for treatment. This encompasses:
Specialized SUD Facilities: Freestanding residential, inpatient, partial hospitalization, or outpatient addiction treatment centers.
Specialized Units within General Facilities: An identified addiction medicine unit, detox unit, or specialized SUD clinic operating inside a general medical hospital or community mental health center.
Dedicated Medical Personnel: Medical or clinical staff in a general medical facility whose primary clinical function is the provision of SUD diagnosis, treatment, or referral, and who are identified as specialized providers.
Important
General Medical Practice Exclusion: A primary care physician, emergency department physician, or general hospitalist who diagnoses and manages an acute alcohol withdrawal state or screens for SUD during a routine physical is NOT a Part 2 Covered Program, provided the facility does not have a dedicated specialized SUD unit and the clinician does not hold themselves out as an addiction specialist. Their clinical documentation is governed exclusively by HIPAA Privacy Rules , not 42 CFR Part 2.
3. The General Rule of Confidentiality & Patient-Identifying Information
Under 42 CFR § 2.12 and § 2.13 , the general rule prohibits any covered program from making any disclosure—direct or indirect—of patient-identifying information without a fully executed, valid written consent or an explicit statutory exception.
Patient-Identifying Information: Any information (written, verbal, or electronic) that identifies an individual, directly or indirectly, as having or having had a substance use disorder, being diagnosed with an SUD, or having applied for or received SUD treatment or referral from a covered program.
Indirect Disclosures: Part 2 strictly prohibits indirect disclosures or acknowledgment of presence . If a law enforcement officer, process server, spouse, or employer visits an addiction facility or calls asking, "Is John Doe currently in your facility?" or "Can you confirm John Doe has an appointment today?" , staff cannot answer affirmatively or confirm enrollment. Simply confirming that John Doe is on the premises or is a client constitutes an illegal indirect disclosure that John Doe has a substance use disorder.
Proper Clinical Response: Staff must state: "Under federal confidentiality laws (42 CFR Part 2), I can neither confirm nor deny the presence, admission, or treatment of any individual in our facility without a signed consent form or an authorizing federal court order."
4. Mandatory Elements of a Valid Part 2 Consent Form
Under 42 CFR § 2.31 , a consent form for the release of Part 2 protected records is legally invalid unless it contains all nine mandatory elements . Omission of a single required element renders the document void, and any subsequent release of information constitutes a federal violation. +-----------------------------------------------------------------------------+
- | THE NINE MANDATORY ELEMENTS OF A PART 2 CONSENT |
- | |
- | 1. PATIENT NAME ---> Explicit name of the individual |
- | 2. DISCLOSING ENTITY ---> Specific program/clinician releasing data|
- | 3. RECIPIENT NAME/CLASS ---> Specific individual, entity, or class |
- | 4. PURPOSE OF DISCLOSURE ---> Precise clinical/administrative purpose |
- | 5. SCOPE OF INFORMATION ---> Exact amount & kind of data disclosed |
- | 6. REVOCATION STATEMENT ---> Right to revoke in writing at any time |
- | 7. EXPIRATION DATE/EVENT ---> Finite duration; no longer than needed |
- | 8. PATIENT SIGNATURE ---> Signed by client or legal representative |
- | 9. DATE OF EXECUTION ---> Exact date the consent was signed |
- +-----------------------------------------------------------------------------+
- Detailed Checklist of the 9 Mandatory Part 2 Consent Elements
Element # Mandatory Consent Component Legal & Clinical Requirement under 42 CFR § 2.31 Critical Compliance Pitfalls to Avoid
1 Name of Patient The legal first and last name of the client whose records are to be disclosed. Misspelled names, aliases not legally documented, or blank name fields.
2 Disclosing Entity The specific name of the Part 2 program, facility, or individual clinician authorized to release records. Vague phrases such as "all treating facilities" or leaving the disclosing party blank.
3 Recipient Name / Class The specific name of the individual recipient, organization, or category of entities (e.g., "Dr. Jane Smith at Mercy Hospital" or "My Third-Party Payer / Blue Cross" ). Naming broad, undefined third parties; blanket authorizations to "any requesting entity."
4 Purpose of Disclosure The explicit, narrow reason for the disclosure (e.g., "Coordination of psychiatric care," "Verification of treatment compliance for probation," "Insurance billing and claims processing" ). Vague or all-encompassing purposes such as "at the request of the patient" without clinical context when third parties request records.
5 Kind & Amount of Info The specific data to be disclosed (e.g., "Intake biopsychosocial assessment, toxicology drug screens, and discharge summary only" ). Checking "Entire medical record" when only drug screen results or attendance logs were requested.
6 Right to Revoke A clear statement informing the patient that consent may be revoked in writing at any time, except to the extent that the program has already acted in reliance upon it. Failing to include explicit revocation language; asserting that any consent is permanently irrevocable — even a § 2.35 criminal justice consent must state a specified time or ascertainable event upon which it becomes revocable.
7 Expiration Date or Event A specific calendar date (e.g., "December 31, 2026" ) or a determinate future event (e.g., "30 days following formal discharge from intensive outpatient care" ). Omitting an expiration date; writing "Indefinite" or "Forever" (invalidates the consent).
8 Patient Signature The physical or verified electronic signature of the patient (or legal guardian/personal representative if legally required). Relying on verbal consent over the phone without written/electronic execution; signature by unauthorized third parties.
9 Date of Signature The exact date (day, month, year) on which the consent document was signed. Undated signatures; pre-dating or post-dating documents.
5. Mandatory Notice of Re-disclosure (§ 2.32)
Every disclosure made with the patient's written consent must be accompanied by a formal written Notice of Re-disclosure . This notice legally prohibits the recipient from making any secondary disclosure of the information without obtaining separate, specific written consent from the patient or unless authorized by federal regulations. +-----------------------------------------------------------------------------+
- | MANDATORY PROHIBITION ON RE-DISCLOSURE |
- | |
- | "This information has been disclosed to you from records protected by |
- | federal confidentiality rules (42 CFR Part 2). The federal rules prohibit |
- | you from making any further disclosure of this information unless further |
- | disclosure is expressly permitted by the written consent of the person to |
- | whom it pertains or as otherwise permitted by 42 CFR Part 2. A general |
- | authorization for the release of medical or other information is NOT |
- | sufficient for this purpose. The federal rules restrict any use of the |
- | information to criminally investigate or prosecute any patient with a |
- | substance use disorder." |
- +-----------------------------------------------------------------------------+
6. 42 CFR Part 2 vs. HIPAA Privacy Rule: Comprehensive Comparison
Addiction counselors must understand where HIPAA and 42 CFR Part 2 diverge. The fundamental rule of statutory preemption states that when state or federal laws conflict, the more stringent privacy protection always governs .
Comprehensive Comparative Analysis Matrix
Statutory Feature HIPAA Privacy Rule (45 CFR Parts 160 & 164) 42 CFR Part 2 Regulations (SUD Specific)
Governing Authority U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR). HHS / Substance Abuse and Mental Health Services Administration (SAMHSA) & OCR.
Covered Entities Health plans, healthcare clearinghouses, and healthcare providers transmitting electronic claims. Federally assisted individuals/entities that hold themselves out as providing SUD diagnosis, treatment, or referral.
Protected Information Protected Health Information (PHI): All individually identifiable physical and mental health data. Patient-Identifying SUD Information: Data identifying a patient as having, or having had, an SUD.
Treatment, Payment, & Operations (TPO) Permitted without client consent: Covered entities may freely share PHI for TPO purposes without written authorization. Historically required specific written consent: Modernized under CARES Act to permit a single broad TPO consent.
Re-disclosure of Information General medical records received by a covered entity may be re-disclosed for treatment/payment under standard HIPAA rules. Strictly prohibited: Recipients cannot re-disclose SUD records without specific patient consent or authorizing Part 2 court order (§ 2.32).
Subpoenas for Records A standard attorney-issued or clerk-issued subpoena with satisfactory assurances is sufficient to compel records. Legally INSUFFICIENT: Subpoenas alone cannot compel Part 2 records. Requires an Authorizing Part 2 Subpart E Court Order.
Law Enforcement Access Permitted under broad administrative exceptions (warrants, grand jury subpoenas, crime on premises). Strictly restricted: Law enforcement cannot access records or investigate patients without a specialized § 2.65 court order.
Consent Revocability Patient may revoke HIPAA authorization at any time in writing, except for actions already taken. Patient may revoke Part 2 consent at any time in writing; a § 2.35 criminal justice consent is not revocable at will and instead becomes revocable on the specified time or ascertainable event stated in it.
Civil Enforcement Penalties HITECH Act tiered civil monetary penalties ranging from $100 to $50,000+ per violation (up to $2M/year). Aligned under CARES Act to match full HITECH Act civil monetary penalty tiers and OCR civil enforcement.
7. CARES Act Section 3221 & The 2024/2026 Modernization Final Rule
To address systemic barriers in care coordination, electronic health record (EHR) integration, and medical record interoperability, Section 3221 of the Coronavirus Aid, Relief, and Economic Security (CARES) Act mandated major statutory harmonizations between 42 CFR Part 2 and HIPAA. HHS and SAMHSA released the Final Rule on February 16, 2024 . It became effective April 16, 2024 with a two-year implementation runway, and compliance has been required since February 16, 2026 — so this is current operating law, not a pending change. It introduced the following modernizations: +-----------------------------------------------------------------------------+
- | KEY MODERNIZATIONS UNDER CARES ACT & FINAL RULE |
- | |
- | 1. SINGLE TPO CONSENT ---> One broad consent covers all future TPO |
- | 2. PENALTY HARMONIZATION ---> HITECH civil penalty tiers enforced by OCR|
- | 3. INTEGRATED PRIVACY NOTICE--> Combined HIPAA & Part 2 Privacy Notice |
- | 4. ACCOUNTING DISCLOSURES ---> Right to 3-year EHR disclosure history |
- | 5. ANTI-DISCRIMINATION ---> Strict bans on using records in courts/job|
- | 6. SAFE HARBOR PROTOCOLS ---> Protection for diligent investigating agcy|
- +-----------------------------------------------------------------------------+
Core Modernization Provisions:
Unified Consent for Treatment, Payment, and Health Care Operations (TPO):
Patients may now execute a single broad written consent authorizing a Part 2 program to disclose their SUD records for all future treatment, payment, and health care operations to HIPAA-covered entities.
Once Part 2 records are disclosed to a HIPAA-covered entity under this broad TPO consent, the recipient covered entity may further re-disclose those records in accordance with standard HIPAA Privacy Regulations (until the patient revokes the initial consent in writing).
Civil Penalty Parity with HIPAA:
Historical Part 2 violations carried minor criminal fines ($500 for a first offense, $5,000 for subsequent offenses). Under modernization, violations are subject to the severe, tiered civil monetary penalties of the HITECH Act (enforced by the HHS Office for Civil Rights) , reaching up to $2,000,000+ per year for willful neglect.
Notice of Privacy Practices (NPP) Integration:
Part 2 programs and HIPAA entities must issue an updated, comprehensive Notice of Privacy Practices clearly articulating both Part 2 and HIPAA confidentiality rights, the scope of TPO disclosures, and patient revocation rights.
Right to an Accounting of Disclosures:
Patients who consent to TPO disclosures have the legal right under HIPAA/Part 2 alignment to request an accounting of all non-consensual and electronic health record (EHR) disclosures made during the preceding three years .
Robust Anti-Discrimination Safeguards:
Strengthened federal statutory prohibitions bar the use of Part 2 patient records, testimony, or enrollment status in any civil, criminal, administrative, or legislative proceedings against the patient (including employment, housing, child custody, and driver's licensing) without an explicit § 2.65 authorizing court order or specific consent.
Investigative Agency Safe Harbor:
Protects federal, state, and local law enforcement and regulatory agencies from liability for receiving Part 2 records if they exercised reasonable diligence before applying for an authorizing court order.
8. Permissible Non-Consensual Disclosures Under 42 CFR Part 2
While patient consent is the primary mechanism for releasing records, 42 CFR Part 2 explicitly delineates narrow statutory exceptions where disclosures may occur without patient consent . +-----------------------------------------------------------------------------+
- | PERMISSIBLE NON-CONSENSUAL DISCLOSURES UNDER PART 2 |
- | |
- | [§ 2.51] MEDICAL EMERGENCIES ---> Immediate life/health threat |
- | [§ 2.52] SCIENTIFIC RESEARCH ---> IRB / Privacy Board approval |
- | [§ 2.53] AUDITS & EVALUATIONS ---> Licensure, CMS, Joint Commission |
- | [§ 2.11] QSOAs ---> External vendors (billing, lab, IT)|
- | [§ 2.12(c)(6)] CHILD ABUSE ---> Mandated state abuse reports |
- | [§ 2.12(c)(5)] ON-PREMISES CRIMES ---> Perpetrator ID & crime facts |
- | [§ 2.61-§ 2.67] COURT ORDERS ---> Authorizing Subpart E court order |
- | [§ 2.12(c)(3)] INTERNAL COMMS ---> Need-to-know treating staff |
- +-----------------------------------------------------------------------------+
- Comprehensive Non-Consensual Disclosure Reference Matrix
Exception & Citation Statutory Standard & Scope of Release Specific Legal & Clinical Requirements Documentation Mandate
Medical Emergencies ; (42 CFR § 2.51) Disclosure to bona fide medical personnel treating a condition that poses an immediate threat to the health of any individual requiring emergency medical intervention. Limited strictly to medical personnel providing acute emergency care (e.g., ER doctors, trauma teams, paramedics). Cannot disclose to family members or police under this section. Program must immediately document: name of medical personnel, affiliation, date/time, nature of emergency, and exact info disclosed.
Scientific Research ; (42 CFR § 2.52) Disclosure to qualified scientific researchers who have secured appropriate institutional oversight. Researcher must obtain Institutional Review Board (IRB) or HIPAA Privacy Board approval, establish secure data protocols, and agree never to identify patients in reports. Written research protocol, data use agreements, and IRB human subjects determination letters retained on file.
Program Audits & Evaluations ; (42 CFR § 2.53) Disclosure to authorized government oversight agencies, third-party payers, or accreditation organizations. Reviewers (e.g., SAMHSA, CMS, Joint Commission, CARF) may only access records on-site or via secure encrypted channels and cannot remove identifying data without strict encryption. Formal audit notifications, accreditation agreements, and reviewer non-disclosure certifications.
Qualified Service Organization Agreements (QSOAs) ; (42 CFR § 2.11) Two-way written legal agreement between a Part 2 program and an external entity providing specialized services (billing, lab, legal, IT/EHR). The QSOA legally binds the external vendor to: (1) comply fully with 42 CFR Part 2, (2) safeguard data, and (3) resist in judicial proceedings any effort to obtain patient data. Fully executed, countersigned QSOA document specifying services provided and confidentiality obligations.
Suspected Child Abuse & Neglect ; (42 CFR § 2.12(c)(6)) Exemption allowing mandatory reporting of child abuse and neglect to state Child Protective Services (CPS). Applies strictly to the initial report of abuse facts and identities. Does NOT permit turning over entire treatment records without consent or court order. Copy of initial written child abuse report, CPS case intake confirmation number, and supervisor consultation notes.
Crimes on Premises / Against Staff ; (42 CFR § 2.12(c)(5)) Limited disclosure to law enforcement when a client commits or threatens a crime on facility grounds or against personnel. Restricted strictly to: circumstances of the incident, suspect's name, address, last known whereabouts, and clinical status (cannot release full clinical chart). Incident report, police dispatch/case number, and notification to clinical director.
Authorizing Court Orders ; (42 CFR §§ 2.61–2.67) Disclosure compelled by a specialized Part 2 Authorizing Court Order issued by a judge following a formal "good cause" hearing. Subpoena alone is insufficient. Court must find good cause, lack of alternative means, and essential public interest; records limited to essential data. Certified copy of the Subpart E court order, court transcript/minute order, and matching legal subpoena.
Internal Program Communications ; (42 CFR § 2.12(c)(3)) Communication between or among personnel who have a need for the information in connection with their duties. Clinicians, nursing staff, clinical supervisors, and billing coordinators within the same legal program on a need-to-know basis. Interdisciplinary team notes, clinical supervisory logs, and EHR role-based access audit trails.